Why is Vaishali Pharma falling/rising?

As of 11-Sep, Vaishali Pharma Ltd's stock price is currently at 12.06, reflecting a slight increase of 0.01 or 0.08%. Despite this minor uptick, the stock has been underperforming, as indicated by its performance today, which is down by 0.39% compared to its sector. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 58.29% against the 5-day average. The company has also shown weak long-term fundamentals, with a staggering -145.73% CAGR growth in operating profits over the last five years and a negative EBITDA, which raises concerns about its financial health.
In the broader market context, Vaishali Pharma's recent performance contrasts sharply with the benchmark Sensex, which has gained 1.10% over the past week. The stock has underperformed significantly over various periods, including a -31.05% return year-to-date and a -37.46% return over the past year. This underperformance is compounded by the company's weak ability to service its debt, as indicated by a poor EBIT to interest ratio of 1.68 and a low return on equity of 7.89%. Overall, the combination of declining investor interest, poor financial metrics, and a lack of positive momentum in comparison to the broader market contributes to the stock's ongoing challenges.